Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 13/20 | 0.35 |
| ▸ | TOP2A | P11388 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28897216 | 0.94 | DGKA (0.33) | DGKAEPHX2TOP2A | |
| SCHEMBL28433398 | 0.88 | DGKA (0.39) | DGKAEPHX2 | |
| SCHEMBL28438959 | 0.85 | DGKA (0.33) | DGKAEPHX2TOP2A | |
| SCHEMBL16862571 | 0.81 | ACHE (0.47) | — | |
| SCHEMBL5651628 | 0.78 | CYP1A2 (0.52) | EPHX2TOP2A | |
| SCHEMBL1401029 | 0.77 | ADH1B (0.37) | DGKAEPHX2TOP2A | |
| SCHEMBL23462146 | 0.75 | DGKA (0.44) | DGKAEPHX2 | |
| SCHEMBL9061933 | 0.75 | DGKA (0.44) | DGKAEPHX2 | |
| SCHEMBL6535251 | 0.75 | DGKA (0.59) | DGKA | |
| SCHEMBL9099953 | 0.75 | DGKA (0.55) | DGKAEPHX2TOP2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113226331-A | Medicine for improving infertility or pregnancy state | 山口晃史 | 2021-08-06 | — | — | CN | disclosed |
| CN-112533599-A | Therapeutic agent for humoral immunity-related diseases in maternal-fetal relationship | 山口晃史 | 2021-03-19 | — | — | CN | disclosed |
| EP-0581959-B1 | USE OF MACROLIDE COMPOUNDS FOR EYE DISEASES | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-01-17 | — | — | EP | disclosed |
| US-5770607-A | EYE DROPS CONTAINING TRICYCLO COMPOUND | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-23 | — | — | US | disclosed |
| US-5643901-A | TREATMENT OF UROGENITAL DISORDERS, NERVOUS SYSTEM DISORDERS, ANTIDIABETIC AGENTS OR CARDIOVASCULAR DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-01 | — | — | US | disclosed |
| EP-0428169-B1 | Aqueous liquid formulations | FUJISAWA PHARMACEUTICAL CO (JP) | 1995-03-01 | — | — | EP | disclosed |
| EP-0581959-A1 | USE OF MACROLIDE COMPOUNDS FOR EYE DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-02-09 | — | — | EP | disclosed |
| EP-0533930-A1 | USE OF A MACROLIDE COMPOUND SUCH AS FK 506 FOR MANUFACTURING A MEDICAMENT FOR TREATING IDIOPATHIC THROMBOCYTOPENIC PURPURA AND BASEDOW'S DISEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-31 | — | — | EP | disclosed |
| EP-0428169-A2 | Aqueous liquid formulations | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-22 | — | — | EP | disclosed |
| EP-0406791-A2 | Aqueous liquid composition for external use | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-01-09 | — | — | EP | disclosed |